Moneycontrol PRO
Upcoming Webinar:Watch a panel of experts discuss: Challenges of continuously evolving regulation for Cryptocurrency, on 7th July at 3pm. Register Now

GlaxoSmithKline Consolidated September 2020 Net Sales at Rs 879.32 crore, down 0.31% Y-o-Y

October 29, 2020 / 10:34 AM IST
  • bselive
  • nselive
Todays L/H

Reported Consolidated quarterly numbers for GlaxoSmithKline Pharmaceuticals are:

Net Sales at Rs 879.32 crore in September 2020 down 0.31% from Rs. 882.02 crore in September 2019.

Quarterly Net Profit at Rs. 76.47 crore in September 2020 down 84.79% from Rs. 502.75 crore in September 2019.

EBITDA stands at Rs. 213.90 crore in September 2020 up 1.91% from Rs. 209.89 crore in September 2019.

GlaxoSmithKline EPS has decreased to Rs. 8.30 in September 2020 from Rs. 29.68 in September 2019.


GlaxoSmithKline shares closed at 1,499.55 on October 28, 2020 (BSE) and has given 3.17% returns over the last 6 months and -5.94% over the last 12 months.

GlaxoSmithKline Pharmaceuticals
Consolidated Quarterly Resultsin Rs. Cr.
Net Sales/Income from operations879.32648.59882.02
Other Operating Income------
Total Income From Operations879.32648.59882.02
Consumption of Raw Materials145.61106.7294.56
Purchase of Traded Goods246.87148.42130.05
Increase/Decrease in Stocks-25.012.19145.26
Power & Fuel------
Employees Cost154.01151.92147.47
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses152.98125.27170.67
P/L Before Other Inc., Int., Excpt. Items & Tax182.9092.30171.31
Other Income9.0457.9215.88
P/L Before Int., Excpt. Items & Tax191.94150.22187.19
P/L Before Exceptional Items & Tax191.06149.14186.27
Exceptional Items-64.13--401.14
P/L Before Tax126.93149.14587.41
P/L After Tax from Ordinary Activities76.47110.83502.75
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period76.47110.83502.75
Minority Interest------
Share Of P/L Of Associates------
Net P/L After M.I & Associates76.47110.83502.75
Equity Share Capital169.41169.41169.41
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS8.306.5429.68
Diluted EPS8.306.5429.68
EPS After Extra Ordinary
Basic EPS4.516.5429.68
Diluted EPS4.516.5429.68
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited

ISO 27001 - BSI Assurance Mark